Page 581 - Veterinary Toxicology, Basic and Clinical Principles, 3rd Edition

(2009) n ; (2002) p Vet.

(2009) (2007) (2009) (2007) al. et al. 3/2011: http://www.ema.europa. Vet. trial. 46 49. demodicosis.

al. et Gupta al. et Gupta Barbet (1991) o et Khan web via clinical 121, 1 4. 7, generalized
Comments/References (2010) b Fowler Lanusse (1996) m ; FDA (2009); al. et Lanusse Merola (2009) o ; Plumb (2012) al. et Clayton (2009) al. et Lanusse (2009); al. et Lanusse (2009) al. et Lanusse (2009) al. et Lanusse (2009) al. et Lanusse (2009); al. et Lanusse al. et Tranquilli (2009) al. et Lanusse (2009) al. et Lanusse (2009); al. et Lanusse (2009) al. et Lanusse (2009) al. et Lanusse (2009) al. et Lanusse (2009) al. et Lanusse Accessed 299 303. 88, 59 62. 18, 3/2011: web via Accessed placebo-controlled Wochenschr

Unless http://pmep.cce.cornell.edu/profiles/extoxnet/24d-captan/abamectin-ext.html. EMEA/MRL/186/97-FINAL. Unit. Parasitol. Vet. rats. Dermatol. Vet. llamas. EMEA/MRL/114/96-FINAL. double-blinded, Germany. Southern Cystocaulus and filaria with treated 52, Res. Vet. J. Am. 232 235.

MTD (ABCB1 in and randomized, and http://www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm116793.htm. dogs in collies. 44,

or mg/kg defective) Evaluation muris alpacas Switzerland Dictyocaulus reactions in Toxicol.
(LOEL Stated) PO (ABCB1 PO http://www.inchem.org/documents/jecfa/jecmono/v36je02.htm Medicines Syphacia in Unit. prospective, with oxime Hum.

Dose mg/kg, SC mg/kg, mcg/kg defective);0.2 1 PO mg/kg mg/kg, (ABCB1 of infestation Evaluation a horses: in ruminants infected adverse milbemycin Vet.

Toxic Otherwise 1.0 0.6 80 normal) 0.2 1.2 2 mg/kg 5 mg/kg 1 259. p. Veterinary infections sp. dressage small with of 1998 2000.

2/2011. Blackwell, Products, natural Chorioptes Medicines and in naturally associated is administration from

PO topical (ABCB1 topical topical web via Wiley against of treatment Veterinary contortus sheep in genotype equines
mg/kg, mg/kg mg/kg, mg/kg, Accessed (ed.). 2/2011. Medicinal netobimin hunter/jumper treatment high-dose in cases
NOAEL 0.75 mg/kg, 5 0.6 defective) mg/kg 2 60 60 ME web of and the in Products, in Haemonchus (MDR1-1Delta) by

University. Fowler via York. New Evaluation eprinomectin Medicinal mange of pour-on induced overdose

PO PO SC Accessed the moxidectin resistance web: Delta
Dose SC mg/kg, mg/kg, topical, SC mg/kg, PO PO PO mg/kg/d 7d,PO PO PO SC, mg/kg, PO SC PO, topical topical Cornell Camelids, Safety. Health, for Agency http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500013916.pdf. topical of Evaluation psoroptic of eprinomectin via Accessed ABCB1-1 toxicosis of moxidectin

Therapeutic (Route) 0.2 0.6 0.024 0.4 mg/kg, 0.5 mg/kg, 0.2 0.006 0.6 mg/kg 0.2 0.4 mg/kg, 0.4 mg/kg, 0.2 0.1 mg/kg, 0.2 PO mg/kg, 2 mg/kg, 0.5 mg/kg 0.2 1 Topical 0.003 0.17 PO mg/kg, 0.4 mg/kg, 0.3 mg/kg 0.2 1 mg/kg, 6 mg/kg, 6 Profile. Information of Surgery and Medicine FOIA. Letter, Chemical on Animal Pfizer Information. European sheep). doramectin, of effect The of Efficacy 2007. the for Agency eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500014177.pdf. treatment Eprinomectin Anthelminthic 2009. K.,

(Continued) Species Camelids Cats Cattle Dogs Frogs (Dendrobates spp.) Goats Horses Pigs Sheep Cats Dogs Cattle Dogs Horses Pigs Sheep Cats Dogs Pesticide Abamectin. In Parasites. Approval Dectomaxs Programme International Label Dectomaxs and (pigs Doramectin 2000. S., Dalgic, E., C.K., Cebra, M.A., European Eprinomectin. 2008. S., Kar, B., 353 357. Pfister, M., Mahling, Dolan, E., Kozan, Cats for Heartgards J.M., Gay, T., 111 114. K.S., Todd, A.J., Paul, S.R., Hansen, D.A.,

43.2 1994. 2010. M.E., (1997) 2010. 2006. 1997. Ayaz, H., Kutzler, J.D., 1996. Ulutas, 156, M.C., F., Sevimli, 1996. Snook, J.L., 20, W.J., Kuster, S.A.,

TABLE Agent VetBooks.ir Ivermectin Milbemycin Moxidectin Selamectin a ExToxNet, b Fowler, c FDA d INCHEM, e Pfizer, f EMEA, g Oege, h Plant, i EMEA, j Ural, K., Parasitol. k Scheuerle, l Kırcalı m FDA, n Barbet, Dermatol. o Tranquilli, p Khan,